Status:
COMPLETED
Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Pain
Huntington Disease
Eligibility:
All Genders
18+ years
Brief Summary
According to above basic findings, it is important to confirm those results in clinic. In this branch, the investigators will use patient control analgesic (PCA) device to investigate the consumption ...
Detailed Description
As the investigators all know, pain, as an ancient enemy to human kind, was one of the most mystical phenomena within our body. For centuries, people search the magic wand to solve this issue and reac...
Eligibility Criteria
Inclusion
- Patients with resectable liver tumor and are over 18 years of age.
- Patients who present the will for his/her liver resection.
- Patients who are competent to understand the study and provide written informed consent and participate in outcome measurements.
Exclusion
- Patients have previous liver surgery. Patients are over 65 years of age. Patients are unable to read or write the pain questionaire, any condition that could interfere with the interpretation of outcome assessments, pregnant or lactating women or allergy to morphine.
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01919034
Start Date
April 1 2012
End Date
December 1 2012
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Shengli Rd, Taiwan, 701